Bambusa Therapeutics, Inc. (BBTX) SEC filings
BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.09−0.66 (-3.94%)
Close on Nov 13, 2026Market cap –P/E –Yield –
SEC filings
1 of Bambusa Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 2, 2026 | Nov 3, 2026 | SEC EDGAR |
See a number that looks wrong?